Quest Diagnostics (DGX) Tops Q2 EPS by 5c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| Quest Diagnostics (NYSE: DGX) | Delayed: 239.84 -3.11 (1.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $242.95 | 52 Week High | $86.85 | |||
| Open | $241.96 | 52 Week Low | $59.66 | |||
| Day High | $243.27 | P/E | 45.17 | |||
| Day Low | $239.64 | EPS | $5.31 | |||
| Volume | 281,556 | |||||
